Approvals of COVID-19 vaccines by regulatory authorities have given hope that an end to the acute phase of the pandemic is within reach. To realize the full potential of these vaccines, they must be distributed in an equitable manner that prioritizes health care workers, front line responders (including Red Cross and Red Crescent staff and …
IFRC’s five pillars to prepare for and introduce COVID-19 vaccines Read More »
This document outlines IFRC’s guidance for vaccine introduction and clinical trials, as well as the process for the approval and licensing of new COVID-19 vaccines. This was last updated on January 2021.
The Japanese Red Cross Society issued the “Nuclear Disaster Guidelines for Preparedness, Response and Recovery” (Guidelines) on March 30, 2015, and made some changes to them afterward, in March 2016 and November 2018. Based on the experiences and reflections of the activities conducted soon after the TEPCO’s Fukushima Daiichi Nuclear Power Plant accident (Fukushima Daiichi …
Nuclear Disaster Guidelines – Japanese Red Cross Society – November 2018 Read More »
At the outset of the COVID-19 pandemic, children and youth were facing unprecedented challenges caused by quarantine measures and school closure policies in nearly every country in the world. At the same time these challenges emerged, child-focused organizations found it harder than ever to communicate with children, needing to adapt their methods of hearing children’s …
This WHO document, is an update of the guidance published on 5 June 2020, includes new scientific evidence relevant to the use of masks for reducing the spread of SARS-CoV-2, the virus that causes COVID-19, and practical considerations
A testagem é um componente crítico da resposta à epidemia, pois permite que as autoridades de saúde pública identifiquem os casos individuais e os hotspots emergentes de COVID-19 e implementem rapidamente medidas eficazes de controle da epidemia, como isolamento e tratamento e rastreamento de contatos em casos confirmados para diminuir e parar a propagação do …
Nota de orientação sobre a testagem de SARS-CoV-2 Read More »
As the COVID-19 pandemic spreads, states are facing an unprecedented public health challenge, which has forced them to adopt stringent measures. Against this backdrop, the management of migratory movements adds another layer of complexity – migrants must not be disproportionately affected either by the pandemic itself or by the measures legitimately adopted by states in …
COVID-19 AND THE IMPACT ON MIGRANTS – IFRC Briefing note: Read More »
These documents are a summary of the risk, evidence, and assessment related to COVID-19. These are updated on a weekly basis and past updates can be found under ‘Risk, Evidence, and Modelling’. Future updates will appear in the same location.
the WHO interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used in the context of COVID-19. This includes WHO Priority Medical Devices, specifically: surgical masks, non-surgical masks, gloves, goggles, face shields, gowns and N95 masks
This guidance provides explanations of the types and reliability of different test types and strategies. It is meant to inform effective decision-making by National Societies involved in or considering support to COVID-19 testing. Last updated on October 2020.